Stay Updated with the Latest State Street SPDR Portfolio High Yield Bond ETF SPHY News in Real Time
Find SPHY news now at Meyka AI. Stay informed with the latest State Street SPDR Portfolio High Yield Bond ETF stocks updates, including price news, market analysis, and expert insights.
Dogecoin Jumps 16.1% to $0.0934 as RSI Signals Extreme Overbought
DOGEUSD surged 16.1% to $0.0934 in 24 hours with RSI at 75.78 and volume 2.1x average, signaling an overheated rally.
Bitcoin Cash Surges 23% to $274.84 as Japan Licensing Fuels Institutional Demand
Bitcoin Cash jumped 23.3% to $274.84 on August 23, 2026, after Japan approved its first new crypto trading license in four years, enabling regulated access for professional investors.
Fifth Third Backs Payload’s $500M Monthly Payments Platform on August 23
Fifth Third Bank invests in Payload, an embedded payments platform processing $500M monthly. The deal marks Payload’s first outside capital since 2019 and expands payment options across industries.
Bitcoin Jumps 6.4% to $77,699 as Volatility-Adjusted Rally Signals Regime Shift
Bitcoin surges 6.4% to $77,699 in a volatility-adjusted move analysts compare to the fifth-largest since 2018, signaling a potential bull market inflection.
Toby Greene Weighs Free Agency Move to Victoria as GWS Season Ends, August 24
GWS Giants captain Toby Greene considers free agency move to Victoria after season ends. Coach Adam Kingsley hopeful he will stay but gives star forward time to decide.
Ethereum Surges 5.9% to $2,464.69 as RSI Hits Extreme Overbought 84.7
Ethereum USD jumped 5.9% to $2,464.69 in 24 hours with RSI at 84.7, signaling extreme overbought conditions and a potential pullback.
Solana Climbs 8.5% to $95.08 as RSI Hits Extreme Overbought 78.7
Solana USD surged 8.5% to $95.08 in 24 hours with RSI at 78.7, signaling overbought conditions and potential pullback risk.
Zcash Surges 49.2% to $847.56 as RSI Hits Extreme Overbought 77.9
Zcash USD jumped 49.2% to $847.56 in 24 hours with RSI at 77.9 and volume 2.26x average, signaling extreme overbought conditions.
Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win
Moderna and Merck’s personalized mRNA cancer vaccine succeeded in Phase 3 melanoma trials, reducing disease recurrence. MRNA jumped 8.9% and MRK rose 2.4% on the announcement.